Cameron Wheeler, PhD
Principal, Private Transactions Team
Cameron Wheeler, PhD is a Principal on the Private Transactions Team at Deerfield Management. Dr. Wheeler joined Deerfield in 2014 and focuses on therapeutics companies.
Prior to joining Deerfield, Dr. Wheeler was at Eleven Biotherapeutics (now named Sesen Bio, Inc.), a clinical-stage biopharmaceutical company developing antibody-drug conjugate therapies for treating cancer, for more than five years, where he was responsible for corporate development and commercial strategy. He was instrumental in the founding, building, and the eventual public offering of Eleven Biotherapeutics. Prior to that, he was at Third Rock Ventures, a Boston-based venture capital firm focused on launching and building life-science companies. While at Third Rock, he gained business development and operating experience as a member of the founding team of Constellation Pharmaceuticals, a clinical-stage biopharmaceutical company with expertise in epigenetics used to discover and develop small-molecule therapeutics to treat cancers associated with abnormal gene expression.
Dr. Wheeler holds a PhD and master of science in biological engineering and a bachelor of science in mechanical engineering from the Massachusetts Institute of Technology.